The Post-Trial-and-Error, Post-AI Drug Discovery Platform


Our platform is the product of fundamental advancements in molecular physics, directed synthesis, integrated preclinical characterization, machine learning, and much much more...

Virtual exploration of novel chemical space comprising 1033 drug-like compounds

Ab initio quantum & semi-classical physics modeling of protein-drug interactions

Streamlined synthesis pathways driven by computer-generated instructions

Efficient biological testing & AI-based optimization of multiple candidate families